DCM
DAFNA Capital Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-550,940
| Closed | -$5.56M | – | 77 |
|
|
2022
Q4 | $5.56M | Buy |
550,940
+11,000
| +2% | +$111K | 1.57% | 19 |
|
|
2022
Q3 | $12.1M | Sell |
539,940
-11,000
| -2% | -$247K | 3.25% | 8 |
|
|
2022
Q2 | $13.7M | Buy |
550,940
+50,010
| +10% | +$1.24M | 3.72% | 5 |
|
|
2022
Q1 | $19.4M | Buy |
500,930
+128,770
| +35% | +$4.99M | 5.06% | 3 |
|
|
2021
Q4 | $21.8M | Buy |
372,160
+27,800
| +8% | +$1.63M | 5.48% | 3 |
|
|
2021
Q3 | $20.4M | Buy |
344,360
+30,000
| +10% | +$1.78M | 5.41% | 3 |
|
|
2021
Q2 | $27.3M | Hold |
314,360
| – | – | 5.71% | 2 |
|
|
2021
Q1 | $25.9M | Sell |
314,360
-20,000
| -6% | -$1.65M | 6.15% | 2 |
|
|
2020
Q4 | $30.4M | Sell |
334,360
-104,100
| -24% | -$9.47M | 9.05% | 2 |
|
|
2020
Q3 | $17.5M | Sell |
438,460
-52,401
| -11% | -$2.09M | 5.7% | 4 |
|
|
2020
Q2 | $16.8M | Buy |
490,861
+20,861
| +4% | +$716K | 4.86% | 3 |
|
|
2020
Q1 | $10.4M | Hold |
470,000
| – | – | 4.36% | 3 |
|
|
2019
Q4 | $9.2M | Hold |
470,000
| – | – | 3.16% | 7 |
|
|
2019
Q3 | $7.3M | Buy |
470,000
+409,969
| +683% | +$6.37M | 2.75% | 7 |
|
|
2019
Q2 | $1.22M | Buy |
+60,031
| New | +$1.22M | 0.46% | 54 |
|
|
2015
Q2 | – | Sell |
-20,190
| Closed | -$99K | – | 79 |
|
|
2015
Q1 | $99K | Sell |
20,190
-38,920
| -66% | -$191K | 0.08% | 67 |
|
|
2014
Q4 | $297K | Sell |
59,110
-16,820
| -22% | -$84.5K | 0.23% | 51 |
|
|
2014
Q3 | $387K | Hold |
75,930
| – | – | 0.39% | 41 |
|
|
2014
Q2 | $479K | Buy |
+75,930
| New | +$479K | 0.45% | 33 |
|